DiLab enters Distribution Agreement with Bio Research Center
DiLab AB in Lund has signed a distributor agreement with Japanese company Bio Research Center for distribution of its AccuSampler products in Japan. Japan is one of the largest markets in preclinical pharma research and an important market for DiLab.
DiLab AB develops and globally markets instruments for pharmacological research. The primary customers are life science companies and CRO organisations. The products are mainly used for automation of measurement and analysis in pre-clinical in vivo studies. The AccuSampler, DiLab's main product, offers customers automated blood sampling animal studies. The products of the company are characterised by high quality providing higher productivity and accuracy for the customer. Due to an active research and development programme, the product portfolio of DiLab grows continuously. Several launches of new products are planned during the coming few years. The founder and the two Swedish venture capital organisations Industrifonden and SEB Företagsinvest own the company.
For further information please contact:
Martin Waleij,
CEO
Tel: +46 46 3769 92
Email: martin.waleij@dilab.se
Or visit: http://www.dilab.com
